| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 106.03B | 106.62B | 107.38B | 97.75B | 91.94B | 91.94B |
| Gross Profit | 25.78B | 25.58B | 26.65B | 21.75B | 20.72B | 19.61B |
| EBITDA | 9.07B | 8.66B | 10.68B | 7.19B | 6.98B | 6.29B |
| Net Income | 4.20B | 3.82B | 4.67B | 2.92B | 3.28B | 1.41B |
Balance Sheet | ||||||
| Total Assets | 110.54B | 113.65B | 116.63B | 106.32B | 100.24B | 101.02B |
| Cash, Cash Equivalents and Short-Term Investments | 16.38B | 13.43B | 15.47B | 10.66B | 12.45B | 15.12B |
| Total Debt | 3.12B | 3.71B | 5.54B | 3.29B | 4.60B | 9.57B |
| Total Liabilities | 43.80B | 47.19B | 52.78B | 47.86B | 44.68B | 48.48B |
| Stockholders Equity | 61.43B | 60.97B | 58.25B | 53.78B | 51.45B | 49.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.03B | 3.57B | 151.00M | 2.72B | 5.01B |
| Operating Cash Flow | 0.00 | 5.04B | 5.94B | 2.25B | 4.14B | 7.05B |
| Investing Cash Flow | 0.00 | -3.75B | -2.31B | -1.92B | -1.46B | -1.91B |
| Financing Cash Flow | 0.00 | -3.35B | 1.18B | -2.20B | -5.78B | 1.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥82.33B | 8.23 | ― | 1.61% | -3.41% | 13.79% | |
75 Outperform | ¥171.93B | 16.57 | ― | 1.53% | 3.37% | 21.35% | |
72 Outperform | ¥54.27B | 12.37 | ― | 0.91% | 5.28% | 18.38% | |
72 Outperform | ¥134.11B | 3.86 | 8.07% | 2.64% | 79.29% | 35.48% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥1.63T | 19.95 | 12.05% | 1.50% | 5.44% | -5.19% | |
59 Neutral | ¥49.52B | -60.12 | ― | 5.01% | -32.74% | -117.06% |